What Is Glow GHK CU 70MG?
Glow GHK CU 70MG is a research-grade copper peptide containing GHK-Cu (glycyl-L-histidyl-L-lysine-copper). It is widely studied in skincare research and cosmetic science for its potential to support skin renewal, collagen synthesis, and cellular signalling.
The 70mg formulation refers to the concentration of the peptide for research or formulation purposes.
⚠️ Glow GHK CU 70MG is not a licensed medicine in the UK and should not be used for unregulated medical or cosmetic purposes. This information is strictly educational and research-focused.
How Glow GHK CU 70MG Works
GHK-Cu peptides are researched for their ability to:
-
Support collagen and elastin production
-
Promote skin firmness and structural integrity
-
Influence cellular signalling pathways relevant to skin health
-
Act as antioxidant and tissue repair modulators in laboratory studies
Glow GHK CU 70MG is studied primarily in cosmetic science and research contexts, not as a clinical treatment.
Is Glow GHK CU 70MG Available in the UK?
Glow 70MG can be supplied in the UK for research or formulation purposes only.
It is important to note:
-
It is not MHRA-approved as a medicine or cosmetic treatment
-
Products should be clearly labelled for laboratory or educational research
-
It is not intended for self-administration or unregulated cosmetic use
⚠️ Avoid sites that claim therapeutic or weight-loss effects—these are unsafe and non-compliant.
Who Uses Glow GHK CU 70MG?
Glow 70MG is intended for:
-
Cosmetic science researchers
-
Laboratory and formulation professionals
-
Educational research projects
It is not suitable for personal, clinical, or cosmetic use without professional supervision.
Potential Research Benefits
While not consumer claims, research highlights of GHK-Cu peptides include:
-
Collagen and elastin support
-
Skin structural reinforcement
-
Tissue signalling and cellular renewal
-
Antioxidant pathway research
These outcomes are studied in research settings, not guaranteed for consumer use.




Reviews
There are no reviews yet.